Ron Mekler Joins AppYea's Board of Directors Audit Committee Chair
Ron Mekler Joins AppYea's Board of Directors Audit Committee Chair
GAN YAVNE, ISRAEL / ACCESSWIRE / January 23, 2023 / AppYea Inc. (OTCQB:APYP) which focuses on the development of accurate wearable monitoring solutions to treat sleep apnea and snoring, is pleased to announce the addition of Ron Mekler as an independent director of the Company and Chair of the Audit Committee, effective immediately.
甘亞夫涅，以色列/交通線路/2023 年 1 月 23 日/阿比亞公司（OTCQB：APYP）其中 專注於開發準確的可穿戴式監測解決方案，以治療睡眠呼吸暫停和打鼾，很高興地宣布加入 Ron Mekler 擔任公司獨立董事和審計委員會主席，立即生效。
The appointment is intended to strengthen the board of directors and management of the company, using the experience and connections of Mr. Mekler.
該任命旨在利用 Mekler 先生的經驗和聯繫來加強公司董事會和管理層。
During the last 20 years Mr. Mekler has been serving in key positions including as CFO at Clalit Health Services - The largest Health Services organization in Israel (more than 2,000 employees, 600,000 members) and Controller in several international Industrial and Real Estate Companies.
在過去的 20 年中，Mekler 先生一直擔任關鍵職位，包括在 Clarit 健康服務部門擔任首席財務官-以色列最大的醫療服務組織（超過 2,000 名員工，600,000 名成員）以及多家國際工業和房地產公司的控制者。
Mr. Mekler started his career as an intern at Price Water House Coopers (BIG4) - Specializing in Industrial, Real Estate and High-Tech Companies.
Mekler 先生的職業生涯始於普萊斯水上公司庫珀斯（BIG4）的實習生-專門從事工業，房地產和高科技公司。
Mr. Mekler is a certified accountant since 2003 (from BGU University) and has MBA in Business Management from the Ono Academic College.
Mekler 先生自 2003 年起（來自 BGU 大學）擔任註冊會計師，並擁有大野學術學院的商業管理工商管理碩士學位。
"I am happy to take part in AppYea and believe in the potential of the company and its products in the international market. In recent years, we have seen a growing awareness of the importance of sleep monitoring in general and sleep breathing monitoring in particular, as evidenced by the entry of giant companies into the field. I think this trend will continue. I believe that the company's patent portfolio is a strategic asset that will attract companies to cooperate with the AppYea," said Mr. Mekler.
「我很高興參加 AppYEA，並相信公司及其產品在國際市場上的潛力。近年來，我們對睡眠監測的重要性和尤其是睡眠呼吸監測的重要性越來越多的認識，這證明了巨型公司進入該領域的證明。我認為這種趨勢將繼續下去。我相信公司的專利組合是一項戰略資產，它將吸引公司與 AppYEA 合作，」 梅克勒先生說。
"I congratulate Ron on joining the team and thank him for expressing his trust in the company. I am convinced that Ron will contribute from his vast experience and professionalism to the advancement of the company." Said Boris (Bary) Molchadsky, the Chairman and CEO of AppYea.
「我祝賀 Ron 加入團隊，並感謝他對公司的信任。我深信，Ron 將從他豐富的經驗和專業精神為公司的發展做出貢獻。」 說鮑里斯（巴里）莫爾查斯基，阿比亞的主席兼首席執行官。
About SleepX
關於睡眠
SleepX is the research and development subsidiary of AppYea. The Company has developed a unique product for monitoring and treating sleep apnea and snoring. The technology is protected by several international patents. The Company currently focuses its activities on commercialization of its first product DreamIT.
SleepX 是 AppYEA 的研發子公司。公司開發了一種獨特的產品，用於監測和治療睡眠呼吸暫停和打鼾。該技術受到多項國際專利的保護。該公司目前專注於其第一個產品的商業化活動 夢想之旅。
Cautionary Note Regarding Forward-Looking Statements
有關前瞻性陳述的注意事項
Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future performance of AppYea are subject to many factors including, but not limited to, the sufficiency or working capital and our ability to raise the capital needed to fund our development efforts, timing of product development, FDA approval/clearance of products in development, customer acceptance of our products in the market, the introduction of competitive products, the impact of any product liability or other adverse litigation, commercialization and technological difficulties, and the other risks identified in the S-1 resale registration statement filed with the Securities and Exchange Commission. Such statements are based upon the current beliefs and expectations of management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward-looking statements, whether as a result of future events, new information, or otherwise.
本新聞稿中包含的陳述並非歷史性質，是根據 1995 年《私人證券訴訟改革法》的安全港規定所作出的前瞻性陳述。有關 AppYEA 未來表現的聲明受許多因素影響，包括但不限於我們的充足或營運資金以及我們籌集資金所需資金的能力，產品開發時間，FDA 批准/清關產品，客戶在市場上接受我們的產品，引入競爭產品，任何產品責任或其他不利訴訟的影響，在技術上發現的其他不利訴訟和商業化風險，在 S-1 轉售向美國證券交易委員會提交的註冊聲明。這些陳述是根據目前管理層的信念和期望，並承受重大的風險和不確定性。實際結果可能與前瞻性陳述中列出的結果不同。本新聞稿中包含的前瞻性聲明自本文日期起作出，我們並不承擔任何更新任何前瞻性聲明的義務，無論是由於未來事件，新信息或其他原因造成的。
Contact:
聯繫方式：
Asaf Porat, CFO
asaf@sleepxclear.com
+972-546-864-110
阿薩夫波拉特，首席財務官
asaf@sleepxclear.com
+972-546-864-110
SOURCE: AppYea Inc.
來源： 阿比亞股份有限公司
譯文內容由第三人軟體翻譯。